The M22-A3 standard provides specific quality assurance procedures for both manufacturers and users of ready-to-use microbiological culture media. Its primary goal is to ensure that the media used in clinical diagnostics can accurately support the growth of significant microorganisms. Key Benefits for Your Lab Reduced Retesting:

Since January 2016, US labs subject to CLIA regulations often move toward Individualized Quality Control Plans (IQCP), but M22-A3 remains a technically valid and valuable resource in the CLSI library. Why Standards Matter in 2026 Even as we look toward 2026 CLSI guidelines

Available for purchase as a PDF or as part of a subscription on the ANSI Webstore . Join the Conversation

Direct, legal access to the full document is available through authorized standards organizations. Because these documents are protected by copyright, they typically require a purchase rather than a free download.